These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11324501)

  • 1. Overexpression of p53, EGFR, c-erbB2 and c-erbB3 in endometrioid carcinoma of the ovary.
    Leng J; Lang J; Shen K; Guo L
    Chin Med Sci J; 1997 Jun; 12(2):67-70. PubMed ID: 11324501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of epidermal growth factor receptor (EGFR) in endometrioid carcinoma of the ovary].
    Leng J; Lang J; Guo L
    Zhonghua Yi Xue Za Zhi; 1996 Apr; 76(4):281-3. PubMed ID: 8758275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of P53, P63, and C-erbB-2 in endometrioid adenocarcinoma and their clinicopathological significance].
    Hu WF; Liu MQ; Zhao Q
    Ai Zheng; 2004 Sep; 23(9):1021-5. PubMed ID: 15363194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?
    Alvarez T; Miller E; Duska L; Oliva E
    Am J Surg Pathol; 2012 May; 36(5):753-61. PubMed ID: 22498825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 and HER-2/neu overexpression in ovarian borderline tumors.
    Eltabbakh GH; Belinson JL; Kennedy AW; Biscotti CV; Casey G; Tubbs RR
    Gynecol Oncol; 1997 May; 65(2):218-24. PubMed ID: 9159328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of p53 and c-erbB-2 expression in ovarian endometrioid carcinomas arising in endometriosis.
    Prefumo F; Venturini PL; Fulcheri E
    Int J Gynecol Pathol; 2003 Jan; 22(1):83-8. PubMed ID: 12496703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer.
    Shun CT; Wu MS; Lin JT; Chen SY; Wang HP; Lee WJ; Wang TH; Chuang SM
    Hepatogastroenterology; 1997; 44(14):604-9. PubMed ID: 9164544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between expressions of p53, c-erbB2 genes, proliferating cell nuclear antigen and prognosis of patients with ovarian epithelial carcinoma].
    Li JD; Li MD; Li YF; Huang X; Liu JH; Liu FY; Zhang CQ
    Ai Zheng; 2002 Mar; 21(3):292-6. PubMed ID: 12451998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 mutations and overexpression affect prognosis of ovarian endometrioid cancer but not clear cell cancer.
    Okuda T; Otsuka J; Sekizawa A; Saito H; Makino R; Kushima M; Farina A; Kuwano Y; Okai T
    Gynecol Oncol; 2003 Mar; 88(3):318-25. PubMed ID: 12648581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case-matched molecular comparison of extraovarian versus primary ovarian adenocarcinoma.
    Kowalski LD; Kanbour AI; Price FV; Finkelstein SD; Christopherson WA; Seski JC; Naus GJ; Burnham JA; Kanbour-Shakir A; Edwards RP
    Cancer; 1997 Apr; 79(8):1587-94. PubMed ID: 9118043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transitional cell tumors of the ovary: a comparative clinicopathologic, immunohistochemical, and molecular genetic analysis of Brenner tumors and transitional cell carcinomas.
    Cuatrecasas M; Catasus L; Palacios J; Prat J
    Am J Surg Pathol; 2009 Apr; 33(4):556-67. PubMed ID: 19033864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.
    Mandai M; Konishi I; Koshiyama M; Mori T; Arao S; Tashiro H; Okamura H; Nomura H; Hiai H; Fukumoto M
    Cancer Res; 1994 Apr; 54(7):1825-30. PubMed ID: 7907945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of expression patterns of c-erbB-2, p53, p16INK4A, p27KIP1, cyclin D1 and epidermal growth factor receptor in oesophageal adenocarcinoma: a tissue microarray study.
    Langer R; Von Rahden BH; Nahrig J; Von Weyhern C; Reiter R; Feith M; Stein HJ; Siewert JR; Höfler H; Sarbia M
    J Clin Pathol; 2006 Jun; 59(6):631-4. PubMed ID: 16731604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Overexpression of C-erbB3 in transitional cell carcinoma of the ovary].
    Shen K; Lang J; Guo L
    Zhonghua Fu Chan Ke Za Zhi; 1995 Nov; 30(11):658-61. PubMed ID: 8745489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
    Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S
    Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical detection of p53 protein, c-erbB-2 protein, epidermal growth factor receptor protein and proliferating cell nuclear antigen in gastric carcinoma.
    Jang WI; Yang WI; Lee CI; Kim HS; Song KS; Cho MY; Park JK; Shim YH
    J Korean Med Sci; 1993 Aug; 8(4):293-304. PubMed ID: 7911025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of c-erbB-2, EGF and EGFR expression with postoperative survival of patients with advanced carcinoma of the stomach.
    Czyzewska J; Guzinska-Ustymowicz K; Kemona A
    Folia Histochem Cytobiol; 2009; 47(4):653-61. PubMed ID: 20430735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-associated macrophages, epidermal growth factor receptor correlated with the triple negative phenotype in endometrial endometrioid adenocarcinoma.
    Jiang XF; Tang QL; Shen XM; Li HG; Chen LH; Wang XY; Luo X; Lin ZQ; Jiang GY
    Pathol Res Pract; 2012 Dec; 208(12):730-5. PubMed ID: 23122929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of HER-2/neu is not a risk factor in ovarian clear cell adenocarcinoma.
    Tanabe H; Nishii H; Sakata A; Suzuki K; Mori Y; Shinozaki H; Watanabe A; Ochiai K; Yasuda M; Tanaka T
    Gynecol Oncol; 2004 Sep; 94(3):735-9. PubMed ID: 15350366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic significance of c-erbB-2 and p53 protein expressions in gastric carcinoma--a multivariate analysis of prognostic factors.
    Kim JP; Oh ST; Hwang TS; Chi JG
    J Korean Med Sci; 1994 Jun; 9(3):248-53. PubMed ID: 7993593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.